GlassScriptPhysician profile
Hanheung Lee
NPI 1477572469
$1,886.52
in general payments reported to CMS, 2019-2025
12 companies · $77.52 in 2025
The $77.52 reported for 2025 was less than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,133 · 2020: $234 · 2021: $191 · 2022: $12.56 · 2023: $79.31 · 2024: $159 · 2025: $77.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $316.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $316.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $473.46 | 2019-2025 | Abilify Asimtufii, Abilify Maintena |
| Lundbeck LLC | $256.63 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $241.40 | 2019-2025 | Invega Sustenna |
| Alkermes, INC. | $197.65 | 2019-2025 | Aristada, Lybalvi |
| Neurocrine Biosciences, INC. | $190.97 | 2019-2020 | |
| Abbvie INC. | $148.03 | 2021-2024 | |
| Indivior INC. | $115.03 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $98.49 | 2021-2025 | Caplyta |
| Takeda Pharmaceuticals U.S.A., INC. | $72.87 | 2019 | |
| Allergan, INC. | $56.44 | 2019-2020 | |
| Vanda Pharmaceuticals INC. | $23.20 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hanheung Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.